The latest report from the Childhood Cancer Survivor Study highlights the effect of cancer therapy on endocrine abnormalities over >30 years of follow up. Overall, 44% of patients had one endocrine abnormality, 16.7% had two and 6.6% had three or more. The findings highlight the need for long-term endocrine monitoring of these patients.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Mostoufi-Moab, S. et al. Endocrine abnormalities in aging survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J. Clin. Oncol. http://dx.doi.org/10.1200/JCO.2016.66.6545 (2016).
American Academy of Pediatrics Section on Hematology/Oncology Children's Oncology Group. Long-term follow-up care for pediatric cancer survivors. Pediatrics 123, 906–915 (2009).
National Cancer Institute. Suveillance, Epidemiology, and End Results Program. SEER data, 1973–2013. http://seer.cancer.gov/data/ (2016).
Oeffinger, K. C. et al. Chronic health conditions in adult survivors of childhood cancer. N. Engl. J. Med. 355, 1572–1582 (2006).
Brabant, G. et al. Hypothyroidism following childhood cancer therapy — an under diagnosed complication. Int. J. Cancer 130, 1145–1150 (2012).
Wallace, W. H. et al. Developing strategies for long-term follow-up of survivors of childhood cancer. BMJ 323, 271–274 (2001).
Greenfield, D. M. et al. Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study. J. Clin. Endocrinol. Metab. 92, 3476–3482 (2007).
US National Library of Medicine. ClinicalTrials.gov https://clinicaltrials.gov/ct2/show/NCT01160341?term (2016).
Kremer, L. C. et al. A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group. Paeditr. Blood Cancer 60, 543–549 (2013).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Gleeson, H. Optimizing endocrine care for survivors of childhood cancer. Nat Rev Endocrinol 12, 564–565 (2016). https://doi.org/10.1038/nrendo.2016.152
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2016.152